DMIIU Company Profile and Key Details

NASDAQ : DMIIU

Drugs Made In America Acquisition II Unit

$10.25

0.05+0.49%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock surged +0.49%, trading at $10.25 on NASDAQ, up from the previous close of $10.20. The stock opened at $10.25, fluctuating between $10.25 and $10.25 in the recent session.

Stock Snapshot

10.2

Prev. Close

712.83M

Market Cap

10.25

Day Low

N/A

P/E Ratio

N/A

EPS (TTM)

N/A

Cash Flow per Share

10.25

Open

69.54M

Number of Shares

10.25

Day High

N/A

Free Float in %

N/A

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	10.25	10.25	10.25	10.25	0
Sep 09, 2026	10.25	10.25	10.25	10.25	16
Sep 08, 2026	10.25	10.25	10.25	10.25	17
Sep 03, 2026	10.25	10.25	10.25	10.25	0
Sep 01, 2026	10.25	10.25	10.25	10.25	2
Aug 31, 2026	10.25	10.25	10.25	10.25	21
Aug 28, 2026	10.25	10.25	10.25	10.25	2
Aug 27, 2026	10.25	10.25	10.25	10.25	28
Aug 25, 2026	10.25	10.25	10.25	10.25	33
Aug 18, 2026	10.25	10.25	10.25	10.25	0
Aug 17, 2026	10.19	10.20	10.19	10.20	1.76K
Aug 12, 2026	10.17	10.20	10.17	10.17	2.67K
Aug 11, 2026	10.15	10.15	10.15	10.15	101
Aug 10, 2026	10.18	10.18	10.18	10.18	100
Aug 05, 2026	10.14	10.14	10.14	10.14	6
Jul 30, 2026	10.15	10.15	10.15	10.15	3
Jul 23, 2026	10.16	10.16	10.16	10.16	2.29K
Jul 21, 2026	10.16	10.16	10.13	10.14	6.89K
Jul 15, 2026	10.16	10.16	10.16	10.16	1.24K
Jul 13, 2026	10.16	10.16	10.16	10.16	3

Contact Details

New York, NY 10170

United States

https://dmaacorp.com/954 870 3099

About Company

DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is successfully finalized.

Stock Peers

DWACU

10.08+19.66%

Digital World Acquisition Corp.$61.35 DWAC

13.01+35.22%

Digital World Acquisition Corp.$49.95 RFAIU

-0.00000170.00%

RF Acquisition Corp II Unit$47.01 TENKU

6.4+17.02%

TenX Keane Acquisition Corp.$44.00 TENK

3+8.00%

TenX Keane Acquisition Ordinary Share$40.50 NOVVU

Nova Vision Acquisition Corporation$39.46 NOVV

Nova Vision Acquisition Corporation$37.00 GATE

Marblegate Acquisition Corp.$36.05 GATEU

3.04+11.16%

Marblegate Acquisition Corp.$30.28 RFAI

-1.91-5.97%

RF Acquisition Corp II Ordinary Shares$30.10

Company Overview

Drugs Made In America Acquisition II Corp. Unit (NASDAQ:DMIIU) closed at $10.25 USD, gaining $0.05 (0.49%) from the previous close of $10.20. The stock is currently within 5% of its 52-week low $9.94 and $10.80. With a market capitalization of about $712.83 million, Drugs Made In America Acquisition II Corp. Unit is classified as a small-cap and shows lower-than-market volatility (beta ~0.06). Key stats such as the average daily volume over the past year has been around 482.00 shares, volume is running light vs its 52-week average. Headquartered in New York, NY, Drugs Made In America Acquisition II Corp. Unit operates in the Financial Services sector and the Shell Companies industry. Led by CEO Roger Bendelac, the company employs approximately 2 people and listed since September 25, 2025. DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 0.0%, SMA50 0.16%, SMA200 0.16%). The stock’s 14-day RSI is 51.1 (neutral), while the ATR of 0.02 points to tighter daily ranges. The stock remains sitting in the mid-range of its 52-week band, trading -0.4% below its high and over 0.86% above its low. Average 10-day trading volume of 8.25 shares is below the 3-month average of 571.39, indicating normal recent market interest.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Price Forecast & Outlook

Our AI price prediction model suggests that Drugs Made In America Acquisition II Corp. Unit stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

currently trading near 52-week highs band.

Frequently Asked Questions

What is the current Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock price?

Drugs Made In America Acquisition II Corp. Unit (NASDAQ: DMIIU) stock price is $10.25 in the last trading session. During the trading session, DMIIU stock reached the peak price of $10.25 while $10.25 was the lowest point it dropped to. The percentage change in DMIIU stock occurred in the recent session was 0.49% while the dollar amount for the price change in DMIIU stock was $0.05.

DMIIU's industry and sector of operation?

The NASDAQ listed DMIIU is part of Shell Companies industry that operates in the broader Financial Services sector. Drugs Made In America Acquisition II Corp. Unit designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of DMIIU?

No Data

How DMIIU did perform over past 52-week?

DMIIU's closing price is 3.17% higher than its 52-week low of $9.94 where as its distance from 52-week high of $10.80 is -5.09%.

How many employees does DMIIU have?

Number of DMIIU employees currently stands at 2.

Link for DMIIU official website?

Official Website of DMIIU is: https://dmaacorp.com/

How do I contact DMIIU?

DMIIU could be contacted at phone 954 870 3099 and can also be accessed through its website. DMIIU operates from 420 Lexington Avenue, New York, NY 10170, United States.

How many shares of DMIIU are traded daily?

DMIIU stock volume for the day was 0 shares. The average number of DMIIU shares traded daily for last 3 months was 482.

What is the market cap of DMIIU currently?

The market value of DMIIU currently stands at $712.83M with its latest stock price at $10.25 and 69.54M of its shares outstanding.

Employees	2
Beta	0.06
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Financial Services
Industry	Shell Companies

DMIIU Company Profile and Key Details

Drugs Made In America Acquisition II Unit

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Price Forecast & Outlook

Key Takeaways

Company Overview

Dividend & Fair Value